LG Electronics showcases new infotainment solutions with Taiwan's MediaTek
LG Electronics Inc. said Tuesday it has showcased a next-generation in-vehicle infotainment system in collaboration with Taiwan's semiconductor company MediaTek Inc.
The system, unveiled at the ongoing Auto Shanghai 2025, allows customers to enjoy different content on multiple displays in a vehicle using only one chip and operating system, according to LG Electronics.
Through this collaboration, LG Electronics has integrated MediaTek's "Dimension Auto Platform" system-on-chip with its own multiuser solutions based on an Android-based automotive OS, co-developed with Google.
This development aligns with LG Electronics' broader strategy to expand into next-generation sectors, such as vehicle components, following its withdrawal from the smartphone business in 2021.
Earlier this year, the company also introduced advanced solutions for connected and autonomous vehicles in partnership with tech giant Qualcomm Inc.
"With our innovative solutions and technology, we will continue to expand our partnerships with various global companies to preemptively shape the future vehicle technology ecosystem and lead the transition toward software defined vehicles," said Eun Seok-hyun, vice president at LG Electronics. (Yonhap)
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Korea Herald
4 hours ago
- Korea Herald
T.D. Williamson Announces Strategic Investment from Apollo Funds
TULSA, Okla., June 11, 2025 /PRNewswire/ -- T.D. Williamson ("TDW"), a global leader in pipeline infrastructure technology and services, announced today a strategic investment from funds managed by Apollo (NYSE: APO) (the "Apollo Funds"). SCF Partners, a Houston-based private equity firm specializing in energy & infrastructure services investments that acquired TDW in June 2022, will continue to retain a majority ownership stake. TDW has been a leader in the pipeline maintenance and integrity industry for over 100 years. The company offers a comprehensive suite of maintenance and asset optimization solutions that enhance safety, reliability, and performance throughout the full lifecycle of pipeline infrastructure. A recognized technology leader, TDW holds more than 500 registered patents, including innovations in advanced isolation, integrated pigging, in-line integrity assessment and repair — deployed across both infrastructure and utility end markets. Bob McGrew, CEO of TDW, said, "At TDW, we are committed to delivering best-in-class, technically differentiated solutions to support the evolving needs of the operators of critical pipeline infrastructure. This investment by Apollo Funds, alongside our existing relationship with SCF Partners, marks a significant milestone in our journey as we continue to invest in meeting the needs of our customers through innovation and expanding our global reach." Scott Browning, Partner at Apollo, said, "TDW has a long track record of innovation and serving customers across the pipeline industry value chain. We look forward to supporting TDW management and SCF to accelerate strategic growth initiatives that contribute to the safety, reliability and efficiency of energy infrastructure to help serve global energy demand trends." "For over a century, TDW has stood at the forefront of pipeline integrity and innovation," commented Deviyani Misra-Godwin, Managing Director at SCF. "Over the past three years, we've seen tremendous growth in the company, with the team expanding its technology and product portfolio, deepening customer relationships, and continuing to lead the way on safety and operational excellence. We're honored to continue to work alongside TDW's world-class team and excited to welcome Apollo Funds as a strategic partner in this next chapter of growth." TDW and SCF Partners were advised by Vinson & Elkins LLP, while Kirkland & Ellis LLP advised the Apollo Funds. About T.D. Williamson T.D. Williamson ("TDW") serves the gathering, transmission, and distribution sectors of the pipeline industry with a global portfolio of products and services, including advanced isolation, integrated pigging, integrity assessment and repair solutions. With both onshore and offshore applications, TDW offers expansive pipeline maintenance and asset optimization activities. TDW cultivates long-term relationships with pipeline operators that endure throughout the life of a pipeline. To learn more, visit About Apollo Apollo is a high-growth, global alternative asset manager. In our asset management business, we seek to provide our clients excess return at every point along the risk-reward spectrum from investment grade credit to private equity. For more than three decades, our investing expertise across our fully integrated platform has served the financial return needs of our clients and provided businesses with innovative capital solutions for growth. Through Athene, our retirement services business, we specialize in helping clients achieve financial security by providing a suite of retirement savings products and acting as a solutions provider to institutions. Our patient, creative, and knowledgeable approach to investing aligns our clients, businesses we invest in, our employees, and the communities we impact, to expand opportunity and achieve positive outcomes. As of March 31, 2025, Apollo had approximately $785 billion of assets under management. To learn more, please visit About SCF Partners Founded in 1989, SCF provides equity capital and strategic growth assistance to build and grow leading energy service, equipment, and technology companies that operate throughout the world. SCF has invested in more than 80 platform companies, made more than 370 additional acquisitions, and developed 18 publicly listed energy service and equipment companies over its history. The firm is headquartered in Houston, Texas, and has offices in Aberdeen and Australia. For more information, please visit
Korea Herald
14 hours ago
- Korea Herald
Empowering the Future of HPC: MiTAC Showcases Advanced Server Platforms at ISC High Performance 2025
HAMBURG, Germany, June 10, 2025 /PRNewswire/ -- MiTAC Computing Technology Corp., a subsidiary of MiTAC Holdings Corp. (TSE:3706) and a leading manufacturer in server platform design, unveils its Advanced Server Platforms at ISC High Performance 2025, Booth #A02. Featuring AMD EPYC™ 9005 Series and Intel ® Xeon ® 6 processors, these platforms highlight MiTAC's commitment to delivering robust performance, efficiency, and scalability tailored to specific needs for AI computing. MiTAC introduces its latest Intel-based servers optimized for modern data center workloads: Built on the Intel Xeon 6 architecture, MiTAC's solutions integrate AI accelerators, high-speed I/O, and power-aware design to meet the evolving demands of intelligent computing with a sustainable approach. AMD EPYC™ 9005 Series Platforms: Scalable Computing with Enhanced Sustainability MiTAC leverages the performance-per-watt advantages of AMD EPYC™ 9005 Series processors to deliver next-generation efficiency for AI, HPC, and cloud-native workloads: MiTAC's AMD-based solutions empower organizations to enhance data center sustainability, reduce energy consumption, and scale efficiently—without compromising performance. Experience MiTAC's Commitment to Sustainable Innovation At ISC 2025, MiTAC demonstrates its forward-looking approach to intelligent infrastructure—delivering platforms that support next-generation AI and HPC workloads while advancing data center sustainability. Visit MiTAC at Booth #A02 to discover how our Intel and AMD-powered solutions enable energy-efficient, high-performance computing built for the future of AI, cloud, and hyperscale operations. About MiTAC Computing Technology Corporation MiTAC Computing Technology Corp., a subsidiary of MiTAC Holdings, delivers comprehensive, energy-efficient server solutions backed by industry expertise dating back to the 1990s. Specializing in AI, HPC, cloud, and edge computing, MiTAC Computing employs rigorous methods to ensure uncompromising quality not just at the barebone level but, more importantly, at the system and rack levels—where true performance and integration matter most. This commitment to quality at every level sets MiTAC Computing apart from others in the industry. The company provides tailored platforms for hyperscale data centers, HPC, and AI applications, guaranteeing optimal performance and scalability. With a global presence and end-to-end capabilities—from R&D and manufacturing to global support—MiTAC Computing offers flexible, high-quality solutions designed to meet unique business needs. Leveraging the latest advancements in AI and liquid cooling, along with the recent integration of Intel DSG and TYAN server products, MiTAC Computing stands out for its innovation, efficiency, and reliability, empowering businesses to tackle future challenges.
Korea Herald
18 hours ago
- Korea Herald
ClavystBio and A*STAR Partner to Grow MedTech Ventures in Singapore
SINGAPORE, June 10, 2025 /PRNewswire/ -- ClavystBio, a life sciences investor and venture builder established by Temasek, and the Agency for Science, Technology and Research (A*STAR), Singapore's lead public sector R&D agency, have signed a Memorandum of Understanding (MoU) to create and grow MedTech ventures in Singapore. This partnership will support venture creation, product development, and commercialisation by bringing together ClavystBio and two national initiatives hosted by A*STAR — MedTech Catapult and the Diagnostics Development Hub (DxD Hub) — along with A*STAR's broader MedTech and venture creation capabilities. The partnership comes amid growing momentum in Singapore's biomedical landscape, with MedTech output reaching S$20 billion in 2023. [1] As Asia's MedTech market is projected to grow to US$225 billion (S$304 billion) by 2030, [2] these efforts aim to better position Singapore-based innovations to scale and enter new markets. Over this two-year partnership, the parties will work towards the co-creation of new MedTech ventures, investments into A*STAR affiliated companies, and fostering collaborations between A*STAR and ClavystBio's portfolio companies. By combining complementary strengths — from research and engineering to venture building and funding — the partnership aims to identify promising technologies, shape MedTech projects for market readiness, and support new venture formation to strengthen Singapore's innovation-driven MedTech ecosystem. The partnership will focus on several key areas: "This partnership highlights ClavystBio's commitment to nurturing globally successful medical devices, digital health, and diagnostics companies from Singapore," said Mr Anselm Tan, Digital Health & MedTech Lead at ClavystBio. "By combining ClavystBio's investment and venture-building expertise with A*STAR's deep scientific capabilities and productisation platforms, we are cultivating an ecosystem primed for innovation and commercial success. "A*STAR is committed to nurturing a dynamic MedTech ecosystem that bridges innovation with deep tech companies," said Ms Irene Cheong, Assistant Chief Executive (Innovation & Enterprise) at A*STAR. "This MoU builds on an existing collaboration with ClavystBio and marks a significant step forward in our joint efforts to co-create and grow globally investible MedTech ventures. Through national productisation platforms like MedTech Catapult and DxD Hub, combined with A*STAR's venture creation capabilities, we aim to commercialise more innovations from lab to market and grow a vibrant MedTech ecosystem in Singapore." About ClavystBio ClavystBio is a life sciences investor and venture builder set up by Temasek to accelerate the commercialization of breakthrough ideas into health impact. We invest and partner with founders and entrepreneurs to launch and grow global companies from Singapore. Our focus spans therapeutics, digital health and medtech, with an emphasis on first-in-class science and technology. Our collaborative space, Node 1, provides plug-and-play spaces for ventures that have graduated from incubators to progress to their next milestones. By bringing start-ups together, we foster a vibrant and supportive community. About the Agency for Science, Technology and Research (A*STAR) The Agency for Science, Technology and Research (A*STAR) is Singapore's lead public sector R&D agency. Through open innovation, we collaborate with our partners in both the public and private sectors to benefit the economy and society. As a Science and Technology Organisation, A*STAR bridges the gap between academia and industry. Our research creates economic growth and jobs for Singapore, and enhances lives by improving societal outcomes in healthcare, urban living, and sustainability. A*STAR plays a key role in nurturing scientific talent and leaders for the wider research community and industry. A*STAR's R&D activities span biomedical sciences to physical sciences and engineering, with research entities primarily located in Biopolis and Fusionopolis. For ongoing news, visit About Diagnostics Development Hub (DxD Hub) The Diagnostics Development Hub is a national platform hosted by the Agency for Science, Technology and Research (A*STAR). DxD Hub aims to accelerate the transformation of innovations into clinically validated diagnostic devices that are ready for market adoption. Through impactful products, empowering local enterprises and anchoring global companies in Singapore, DxD Hub contributes to the development of an effective diagnostic devices' ecosystem in Singapore. For ongoing news, visit About MedTech Catapult MedTech Catapult (MC) is a national initiative designed to accelerate the product development and commercialisation of high-value life science instruments and regulated medical devices. MC partners with product owners, local contract manufacturers (CMs), and leverages external design houses, and other key stakeholders to guide innovations from concept to market. Their goal is to strengthen Singapore's medtech ecosystem by providing dedicated engineering, quality assurance, regulatory affairs, clinical affairs, project management and commercialisation support to derisk and support products towards commercialisation and market adoption whilst supporting pull-through to local manufacturing.
